The ProMetic Life Sciences’ (PLI) “Outperform” Rating Reiterate at Royal Bank Of Canada

Short resume:

shares
90%
hold
90%
analysts
90%
news
90%
The ProMetic Life Sciences' (PLI) “Outperform” Rating Reiterate at Royal Bank Of Canada

Royal Bank Of Canada reaffirmed their outperform rating on shares of ProMetic Life Sciences Inc. (TSE:PLI) in a research note released on Thursday morning, StockTargetPrices.
Source DailyQuint
Read More…

More News


Be the first to comment

Leave a Reply

Your email address will not be published.


*